In this interview, Cecilia Hillard, PhD discusses endocannabinoid system (ECS) signaling in depressive disorders. Dr. Hillard describes the effect of exercise on the ECS, and how this may underpin some of the benefits of exercise in patients with depression and other mood disorders. Dr. Hillard discusses emerging results in patients with post-traumatic stress disorder (PTSD) which show a different picture, and ends with a discussion on what we know about the role that the endocannabinoid receptors (CB1 and CB2) play…

This is a recording of a presentation given by Dr. Noelle Patno and Dr. Jennifer Ryan in June 2020, at the “Next Gen Microbiome and Probiotics” virtual conference. This presentation includes an overview of specific microbiota, F. prausnitzii and A. muciniphila, that have been described as next generation microbes and bioindicators of health. Challenges for delivering these microbiota directly as probiotic supplements are also explained. Dietary modification, prebiotics, and supplementation with specific strains of Lactobacillus and Bifidobacterium are described as…

In this interview, Professor Charles Serhan, PhD, DSc describes new work highlighting the connection between specialized pro-resolving mediators (SPMs) and the vagus nerve. Dr. Serhan reflects back at his proudest moments of his career, and on the most exciting recent developments. Finally, Dr. Serhan delivers a message on the state of resolution science today, and what is needed to advance SPM-based therapies in the future. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury…

In this Clinical Minute, Nikky Contractor, PhD discusses the most important factors for healthcare provider to consider when selecting a probiotic for their patient. Important strategies include: Make sure that the probiotic has been identified by its genus, species, and strain. Ensure that probiotics are used in a targeted way for a particular condition. Understand the clinical research that supports the use of a particular probiotic for a specific condition.    

Frank Lipman, MD works to bring new modalities into partnership with Western medicine using an evidence-based approach. In this episode, Dr. Lipman explores a new hybrid path between allopathic and Functional Medicine to discover a higher potential for health and happiness.

The cost of obtaining personalized care can be extremely high for patients, both in terms of seeking care from practitioners as well as in getting advanced laboratory testing done. Michael Ruscio, DNM, DC knows how to solve this problem. He shares his insights and utilizes a common-sense approach on how to make personalized medicine more practical and affordable.

The foundation for our health starts during pregnancy and delivery, but the medical system in the United States performs shockingly less effectively during this crucial period than many third-world countries. Leslie Stone, MD, IFMCP and Emily Rydbom, CN, BHCN, CNP explore exciting possibilities with the potential to radically improve pre- and perinatal care and give the next generation a healthier foundation.

Lisa Mosconi, PhD, a brilliant neuroscientist, reveals the latest research on Alzheimer's disease and on the disproportionate rate that women are affected by Alzheimer's, depression, and anxiety. Get the surprising new estimates regarding the role of genetics, as well as a comprehensive list of what to watch for now and what testing to explore.

HDL cholesterol plays vital roles in lipid biology and coronary heart disease pathophysiology. The main function of HDL is to scavenge for and carry LDL cholesterol away from the arteries and back to the liver, for redistribution, metabolism, and excretion. A high HDL measurement was previously thought to represent high reverse cholesterol transport, conferring heart-protective benefits for patients. But newer research indicates a more complicated HDL picture—where five different HDL forms and unique functionalities are at play. In this MAPS…